![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | BANP | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | Banp (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of BANP mRNA | CTD | PMID:36331819 | BANP | Human | 1,3,5-trinitro-1,3,5-triazinane | decreases expression | ISO | Banp (Rattus norvegicus) | 6480464 | cyclonite results in decreased expression of BANP mRNA | CTD | PMID:25559034 | BANP | Human | 17alpha-ethynylestradiol | multiple interactions | ISO | Banp (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of BANP mRNA | CTD | PMID:17942748 | BANP | Human | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Banp (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of BANP mRNA and Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to BANP promoter] | CTD | PMID:17942748 and PMID:19654925 | BANP | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Banp (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of BANP mRNA | CTD | PMID:33387578 | BANP | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Banp (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of BANP mRNA | CTD | PMID:22298810 | BANP | Human | 2-methylcholine | affects expression | EXP | | 6480464 | beta-methylcholine affects the expression of BANP mRNA | CTD | PMID:21179406 | BANP | Human | 3,3',5,5'-tetrabromobisphenol A | increases expression | ISO | Banp (Mus musculus) | 6480464 | tetrabromobisphenol A results in increased expression of BANP mRNA | CTD | PMID:25172293 | BANP | Human | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Banp (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of BANP mRNA | CTD | PMID:26251327 | BANP | Human | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Banp (Rattus norvegicus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of BANP mRNA | CTD | PMID:30071829 | BANP | Human | 3-chloropropane-1,2-diol | increases expression | ISO | Banp (Rattus norvegicus) | 6480464 | alpha-Chlorohydrin results in increased expression of BANP mRNA | CTD | PMID:28522335 | BANP | Human | 4,4'-sulfonyldiphenol | multiple interactions | ISO | Banp (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of BANP mRNA | CTD | PMID:36041667 | BANP | Human | acrylamide | decreases expression | ISO | Banp (Mus musculus) | 6480464 | Acrylamide results in decreased expression of BANP mRNA | CTD | PMID:30807115 | BANP | Human | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of BANP mRNA | CTD | PMID:32763439 | BANP | Human | aristolochic acid A | increases expression | EXP | | 6480464 | aristolochic acid I results in increased expression of BANP mRNA | CTD | PMID:33212167 | BANP | Human | Aroclor 1254 | increases expression | EXP | | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of BANP mRNA | CTD | PMID:16934159 | BANP | Human | arsane | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of BANP gene | CTD | PMID:25304211 | BANP | Human | arsenic atom | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of BANP gene | CTD | PMID:25304211 | BANP | Human | azoxystrobin | multiple interactions | ISO | Banp (Rattus norvegicus) | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of BANP mRNA | CTD | PMID:33854195 | BANP | Human | Benoxacor | decreases expression | ISO | Banp (Mus musculus) | 6480464 | benoxacor results in decreased expression of BANP mRNA | CTD | PMID:34850242 | BANP | Human | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of BANP mRNA | CTD | PMID:26238291 | BANP | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of BANP 5' UTR | CTD | PMID:27901495 | BANP | Human | benzo[a]pyrene diol epoxide I | decreases expression | EXP | | 6480464 | 7 more ... | CTD | PMID:19150397 | BANP | Human | beta-lapachone | decreases expression | EXP | | 6480464 | beta-lapachone results in decreased expression of BANP mRNA | CTD | PMID:38218311 | BANP | Human | bisphenol A | increases expression | ISO | Banp (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of BANP mRNA | CTD | PMID:25181051 | BANP | Human | bisphenol A | multiple interactions | ISO | Banp (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of BANP mRNA | CTD | PMID:36041667 | BANP | Human | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of BANP gene | CTD | PMID:31601247 | BANP | Human | bisphenol A | decreases methylation | EXP | | 6480464 | bisphenol A results in decreased methylation of BANP gene | CTD | PMID:31601247 | BANP | Human | bisphenol A | increases expression | ISO | Banp (Mus musculus) | 6480464 | bisphenol A results in increased expression of BANP mRNA | CTD | PMID:33221593 | BANP | Human | bisphenol A | increases methylation | ISO | Banp (Rattus norvegicus) | 6480464 | bisphenol A results in increased methylation of BANP gene | CTD | PMID:28505145 | BANP | Human | bisphenol F | decreases expression | ISO | Banp (Mus musculus) | 6480464 | bisphenol F results in decreased expression of BANP mRNA | CTD | PMID:38685157 | BANP | Human | bisphenol F | multiple interactions | ISO | Banp (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of BANP mRNA | CTD | PMID:36041667 | BANP | Human | bromobenzene | decreases expression | ISO | Banp (Rattus norvegicus) | 6480464 | bromobenzene results in decreased expression of BANP mRNA | CTD | PMID:32479839 | BANP | Human | cadmium atom | decreases expression | ISO | Banp (Mus musculus) | 6480464 | Cadmium results in decreased expression of BANP mRNA | CTD | PMID:24067728 | BANP | Human | chlorpyrifos | multiple interactions | ISO | Banp (Rattus norvegicus) | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of BANP mRNA | CTD | PMID:33854195 | BANP | Human | chlorpyrifos | increases expression | ISO | Banp (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of BANP mRNA | CTD | PMID:37019170 | BANP | Human | clofibrate | decreases expression | ISO | Banp (Mus musculus) | 6480464 | Clofibrate results in decreased expression of BANP mRNA | CTD | PMID:17585979 | BANP | Human | cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of BANP mRNA | CTD | PMID:19320972 and PMID:19376846 | BANP | Human | crocidolite asbestos | decreases expression | ISO | Banp (Mus musculus) | 6480464 | Asbestos and Crocidolite results in decreased expression of BANP mRNA | CTD | PMID:29279043 | BANP | Human | diazinon | increases methylation | EXP | | 6480464 | Diazinon results in increased methylation of BANP gene | CTD | PMID:22964155 | BANP | Human | dibenzo[a,l]pyrene | increases expression | ISO | Banp (Mus musculus) | 6480464 | dibenzo(a and l)pyrene results in increased expression of BANP mRNA | CTD | PMID:25908611 | BANP | Human | dimethylarsinic acid | multiple interactions | ISO | Banp (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of BANP mRNA | CTD | PMID:34876320 | BANP | Human | disodium selenite | increases expression | EXP | | 6480464 | Sodium Selenite results in increased expression of BANP mRNA | CTD | PMID:18175754 | BANP | Human | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of BANP mRNA | CTD | PMID:29803840 | BANP | Human | epoxiconazole | decreases expression | ISO | Banp (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of BANP mRNA | CTD | PMID:35436446 | BANP | Human | fonofos | increases methylation | EXP | | 6480464 | Fonofos results in increased methylation of BANP promoter | CTD | PMID:22847954 | BANP | Human | fulvestrant | increases methylation | EXP | | 6480464 | Fulvestrant results in increased methylation of BANP gene | CTD | PMID:31601247 | BANP | Human | fulvestrant | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of BANP gene | CTD | PMID:31601247 | BANP | Human | furan | increases methylation | ISO | Banp (Rattus norvegicus) | 6480464 | furan results in increased methylation of BANP gene | CTD | PMID:22079235 | BANP | Human | furan | increases expression | ISO | Banp (Rattus norvegicus) | 6480464 | furan results in increased expression of BANP mRNA | CTD | PMID:26194646 | BANP | Human | genistein | increases expression | ISO | Banp (Mus musculus) | 6480464 | Genistein results in increased expression of BANP mRNA | CTD | PMID:32186404 | BANP | Human | gentamycin | increases expression | ISO | Banp (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of BANP mRNA | CTD | PMID:33387578 | BANP | Human | glyphosate | multiple interactions | ISO | Banp (Rattus norvegicus) | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of BANP mRNA | CTD | PMID:33854195 | BANP | Human | hydrogen peroxide | decreases expression | EXP | | 6480464 | Hydrogen Peroxide results in decreased expression of BANP mRNA | CTD | PMID:18951874 | BANP | Human | imidacloprid | multiple interactions | ISO | Banp (Rattus norvegicus) | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of BANP mRNA | CTD | PMID:33854195 | BANP | Human | ketamine | decreases expression | ISO | Banp (Rattus norvegicus) | 6480464 | Ketamine results in decreased expression of BANP mRNA | CTD | PMID:20080153 | BANP | Human | lead(0) | affects methylation | EXP | | 6480464 | Lead affects the methylation of BANP gene | CTD | PMID:31636367 | BANP | Human | methamphetamine | increases expression | ISO | Banp (Mus musculus) | 6480464 | Methamphetamine results in increased expression of BANP mRNA | CTD | PMID:26307267 | BANP | Human | methylarsonic acid | multiple interactions | ISO | Banp (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of BANP mRNA | CTD | PMID:34876320 | BANP | Human | ozone | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of BANP mRNA | CTD | PMID:35430440 | BANP | Human | paracetamol | decreases expression | ISO | Banp (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of BANP mRNA | CTD | PMID:32479839 | BANP | Human | paracetamol | increases expression | ISO | Banp (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of BANP mRNA | CTD | PMID:33387578 | BANP | Human | parathion | increases methylation | EXP | | 6480464 | Parathion results in increased methylation of BANP promoter | CTD | PMID:22847954 | BANP | Human | perfluorohexanesulfonic acid | increases expression | ISO | Banp (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in increased expression of BANP mRNA | CTD | PMID:37995155 | BANP | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Banp (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of BANP mRNA | CTD | PMID:36331819 | BANP | Human | phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of BANP mRNA | CTD | PMID:19159669 | BANP | Human | Se-methyl-L-selenocysteine | increases expression | EXP | | 6480464 | selenomethylselenocysteine results in increased expression of BANP mRNA | CTD | PMID:18514395 | BANP | Human | Se-methylselenocysteine | increases expression | EXP | | 6480464 | selenomethylselenocysteine results in increased expression of BANP mRNA | CTD | PMID:18514395 | BANP | Human | silver atom | increases expression | EXP | | 6480464 | Silver results in increased expression of BANP mRNA | CTD | PMID:26014281 | BANP | Human | silver(0) | increases expression | EXP | | 6480464 | Silver results in increased expression of BANP mRNA | CTD | PMID:26014281 | BANP | Human | sodium arsenate | multiple interactions | ISO | Banp (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of BANP mRNA | CTD | PMID:34876320 | BANP | Human | sodium arsenite | decreases expression | ISO | Banp (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of BANP mRNA | CTD | PMID:33145626 | BANP | Human | sodium arsenite | multiple interactions | ISO | Banp (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of BANP mRNA | CTD | PMID:34876320 | BANP | Human | Soman | decreases expression | ISO | Banp (Rattus norvegicus) | 6480464 | Soman results in decreased expression of BANP mRNA | CTD | PMID:19281266 | BANP | Human | sulforaphane | decreases expression | ISO | Banp (Mus musculus) | 6480464 | sulforaphane results in decreased expression of BANP mRNA | CTD | PMID:30529165 | BANP | Human | sunitinib | increases expression | EXP | | 6480464 | Sunitinib results in increased expression of BANP mRNA | CTD | PMID:31533062 | BANP | Human | terbufos | increases methylation | EXP | | 6480464 | terbufos results in increased methylation of BANP promoter | CTD | PMID:22847954 | BANP | Human | tetraphene | decreases expression | ISO | Banp (Mus musculus) | 6480464 | benz(a)anthracene results in decreased expression of BANP mRNA | CTD | PMID:26377693 | BANP | Human | thiabendazole | multiple interactions | ISO | Banp (Rattus norvegicus) | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of BANP mRNA | CTD | PMID:33854195 | BANP | Human | thioacetamide | increases expression | ISO | Banp (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of BANP mRNA | CTD | PMID:34492290 | BANP | Human | titanium dioxide | decreases expression | ISO | Banp (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of BANP mRNA | CTD | PMID:23557971 and PMID:29264374 | BANP | Human | titanium dioxide | decreases methylation | ISO | Banp (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of BANP gene and titanium dioxide results in decreased methylation of BANP promoter alternative form | CTD | PMID:35295148 | BANP | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of BANP mRNA | CTD | PMID:37042841 | BANP | Human | tungsten | decreases expression | ISO | Banp (Mus musculus) | 6480464 | Tungsten results in decreased expression of BANP mRNA | CTD | PMID:30912803 | BANP | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of BANP mRNA | CTD | PMID:22083351 | BANP | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of BANP mRNA | CTD | PMID:25979313 | BANP | Human | vinclozolin | decreases expression | ISO | Banp (Rattus norvegicus) | 6480464 | vinclozolin results in decreased expression of BANP mRNA | CTD | PMID:23869203 | BANP | Human | vinclozolin | increases expression | ISO | Banp (Rattus norvegicus) | 6480464 | vinclozolin results in increased expression of BANP mRNA | CTD | PMID:23034163 | BANP | Human | vorinostat | decreases expression | EXP | | 6480464 | vorinostat results in decreased expression of BANP mRNA | CTD | PMID:22083351 | BANP | Human | zinc atom | multiple interactions | EXP | | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of BANP mRNA | CTD | PMID:18593933 | BANP | Human | zinc(0) | multiple interactions | EXP | | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of BANP mRNA | CTD | PMID:18593933 | |